2018•SSRN Electronic JournalOpen access

International Decision, Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd., No. 16-1220 (U.S. 2018)

Kristen E. Eichensehr

Open full text 0 citations

Abstract

When a foreign country's law is relevant to a case in U.S. federal court and the foreign country files an official statement about the meaning of its law, how should U.S. courts treat the foreign government's representations? In Animal Science Products, Inc. v. Hebei Welcome Pharmaceuticals Co., the Supreme Court of the United States held that [a] federal court should accord consideration to a foreign government's submission, but is not bound to accord conclusive effect to the foreign government's statements. The Supreme Court settled a circuit split and reversed a Second Circuit opinion that had given conclusive effect to the Chinese government's representations about its domestic law. Animal Science Products provides important guidance to federal courts faced with increasingly frequent filings by foreign governments, but it leaves unresolved significant questions about deference to foreign sovereign amici and preserves existing debates about the nature of respectful consideration.

About this research paper

What this paper is about

When a foreign country's law is relevant to a case in U.S. federal court and the foreign country files an official statement about the meaning of its law, how should U.S. courts treat the foreign government's representations? In Animal Science Products, Inc. v. Hebei Welcome Pharmaceuticals Co., the Supreme Court of the United States held that [a] federal court should accord consideration to a foreign government's submission, but is not bound to accord conclusive effect to the foreign government's statements. The Supreme Court settled a circuit split and reversed a Second Circuit opinion that had given conclusive effect to the Chinese government's representations about its domestic law. Animal Science Products provides important guidance to federal courts faced with increasingly frequent filings by foreign governments, but it leaves unresolved significant questions about deference to foreign sovereign amici and preserves existing debates about the nature of respectful consideration.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

When a foreign country's law is relevant to a case in U.S. federal court and the foreign country files an official statement about the meaning of its law, how should U.S. courts treat the foreign government's representations? In Animal Science Products, Inc. v. Hebei Welcome Pharmaceuticals Co., the Supreme Court of the United States held that [a] federal court should accord consideration to a foreign government's submission, but is not bound to accord conclusive effect to the foreign government's statements. The Supreme Court settled a circuit split and reversed a Second Circuit opinion that had given conclusive effect to the Chinese government's representations about its domestic law. Animal Science Products provides important guidance to federal courts faced with increasingly frequent filings by foreign governments, but it leaves unresolved significant questions about deference to foreign sovereign amici and preserves existing debates about the nature of respectful consideration.

Key concepts: Supreme court, Deference, Government (linguistics), Law, Political science, Sovereignty, Foreign policy, Meaning (existential)

Related papers

Back to paper searchBrowse research topicsOriginal source
International Decision, Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd., No. 16-1220 (U.S. 2018) — Research Paper | ScholarLens